期刊文献+

阻断mTOR表达对结肠癌LoVo细胞增殖的影响及机制 被引量:3

Effects of Knock-down of mTOR Gene on Growth and Mechanism of Colon Cancer LoVo Cell
下载PDF
导出
摘要 目的观察RNA干扰(RNAi)特异性阻断哺乳动物雷帕霉素靶蛋白(mTOR)基因表达对结肠癌LoVo细胞体内外增殖的影响及机制。方法实验分3组:正常培养组:未转染的正常培养LoVo细胞;阳性实验组:转染mTOR-RNA干扰质粒的LoVo细胞;阴性对照组:转染空载体质粒的LoVo细胞。MTT法检测LoVo细胞体外生长曲线;平板克隆形成试验分析细胞克隆形成能力;流式细胞仪检测细胞周期和凋亡;高效液相色谱法(HPLC)测定细胞内三磷酸腺苷(ATP)含量。结果阳性实验组细胞生长速度较正常对照组减慢。正常培养组、阳性实验组和阴性对照组细胞克隆形成率分别为(26.8±4.9)%、(11.8±2.1)%和(21.3±4.7)%;与正常培养组比较,阳性实验组细胞克隆形成率显著减少(P<0.01)。与正常培养组相比,阳性实验组G1期细胞数增加8.6%,S期的细胞数减少8.0%,细胞凋亡率增加7.0%(均P<0.01)。正常培养组、阳性实验组和阴性对照组细胞内ATP含量分别为(2.47±0.20)nmol/106、(1.62±0.18)nmol/106和(2.37±0.21)nmol/106;阳性实验组ATP含量明显低于正常培养组(P<0.01)。结论特异性阻断mTOR基因表达可通过遏制能量代谢和诱导细胞凋亡来抑制结肠癌LoVo细胞增殖。 Objective To investigate the effects and mechanism of knock-down the expression of mammalian target of rapamycin (mTOR) gene with RNA interference (RNAi) technique on growth and mechanism of colon cancer LoVo cell. Methods There were three groups in the study. Group 1 (normal group) was the normal cultured LoVo cells. Group 2 (positive experimental group) was the LoVo cells transfected with mTOR-RNAi plasmid vector. Group 3 (negative control group) was the LoVo cells transfected empty plasmid vector as negative control. Cell growth was assessed using MTT assay and tumor colony formation was detected. Cell cycle and apoptotic rate were analyzed via flow cytometry. Furthermore, the contents of adenosine triphosphate (ATP) in LoVo cells were measured by high performance liquid chromatography (HPLC). Results The rates of cell proliferation in the positive experimental group were slower than those in the normal cultured group. The colon formations of LoVo cells in the normal cultured group,the positive experimental group and the negative control group were (26. 8 ± 4. 9)%, (11.8 ±2. 1)% and (21.3 ±4. 7)% respectively. Compared with those in the normal cultured group, the colon formations of LoVo cells in the positive experimental group were decreased significantly, and the ratios of cells in G1 phase were increased by 8.6% and that in S phase were decreased by 8. 0% and those in apoptosis were increased by 7. 0% (all,P〈0. 01). The ATP contents in the normal cultured group, the positive experimental group and the negative control group were (2. 47 ±0. 20) nmol/10^6 , (1.62 ± 0. 18) nmol/10^6 and (2. 37 ± 0. 21 ) nmol/10^6 respectively. The ATP contents in the positive experimental group were lower than those in the normal cultured group (P〈0. 01). Conclusion Our results suggested that selective knock-down of mTOR could suppress LoVo cell proliferation by cutting down energy metabo lism and inducing cell apoptosis.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第3期291-293,297,共4页 Cancer Research on Prevention and Treatment
关键词 结肠肿瘤 哺乳动物雷帕霉素靶蛋白 能量代谢 细胞增殖 细胞凋亡 Colon neoplasms mTOR Energy metabolism Cell proliferation Cell apoptosis
  • 相关文献

参考文献15

  • 1Garber K. Energy deregulation:licensing tumors to grow [J]. Science, 2006,312 (5777) : 1158-1159.
  • 2彭秋平,梁后杰,周琪,周进明,傅晓岚,钟大平.己糖激酶-Ⅱ基因在人结肠癌细胞中的表达及其治疗意义[J].中华医学杂志,2007,87(15):1058-1062. 被引量:12
  • 3Hsu PP, Sabatini DM. Cancer Cell Metabolism: Warburg and Beyond[J]. Cell, 2008,134 (6) : 703 707.
  • 4Shaw R J, Cantley LC. Ras, PI (3) K and mTOR signalling controls tumour cell growth [J]. Nature, 2006,441 (7092) : 424- 430.
  • 5Robey RB, Hay Ni. Akt, hexokinase, mTOR : Targeting cellular energy metabolism for cancer therapy [J]. Drug Discovery Today : Disease Mechanisms, 2005,2 ( 2 ): 239- 246.
  • 6彭秋平,梁后杰,边志衡,周进明,周琪,钟大平.mTOR信号通路调控HK-Ⅱ表达对结肠癌细胞增殖的影响[J].现代肿瘤医学,2007,15(6):760-762. 被引量:5
  • 7彭秋平,刘红梅,冯青青,柯传庆,梁后杰.shRNA真核表达质粒介导的RNA干扰对人结肠癌LoVo细胞mTOR基因表达的抑制作用[J].江西医学院学报,2008,48(4):7-10. 被引量:2
  • 8Xu RH,Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells:a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia [J]. Cancer Res,2005,65(2) :613 -621.
  • 9Guertin DA,Sabatini DM. Defining the role of roTOR in cancer [J]. Cancer Cell, 2007,12 (1) : 9-22.
  • 10Garcia JA,Danielpour D. Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies [J]. Mol Cancer Ther,2008,7(6) : 1347-1354.

二级参考文献37

  • 1杨晓红,万福生,潘泽政,余波,贺慧为,艾春红,张晓春,卢小澍.RNA干扰单独及联合p53基因对肺癌细胞增殖的抑制作用[J].江西医学院学报,2006,46(6):1-3. 被引量:3
  • 2彭秋平,梁后杰,边志衡,周进明,周琪,钟大平.mTOR信号通路调控HK-Ⅱ表达对结肠癌细胞增殖的影响[J].现代肿瘤医学,2007,15(6):760-762. 被引量:5
  • 3Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer, 2004, 4: 891-899.
  • 4Pastorino JG, Hoek JB. Hexokinase Ⅱ: the integration of energy metabolism and control of apoptosis. Curr Med Chem, 2003, 10:1535-1551.
  • 5Shinohara Y, Ishida T, Hino M, et al. Characterization of porin isoforms expressed in tumor cells. Eur J Biochem, 2000, 267:6067-6073.
  • 6Xu RH, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer ceils: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.Cancer Res, 2005, 65 : 613-621.
  • 7Broekemeier KM, Klocek CK, Pfeiffer DR. Proton selective subsrtate of the mitochondrial permeability transition pore:regulation by the redox state of the electron transport chain.Biochemistry, 1998, 37: 13059-13065.
  • 8Petronilli-- V, Penzo D, Seorrano L, et al. The mitoehondrial permeability transition, release of cytochrome C and cell death. J Biol Chem, 2001, 276: 12030-12034.
  • 9Geum YG, Jung HY, Kang MK, et al. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase Ⅱ expression. J Hepatol, 2005, 42: 358-364.
  • 10Geschwind JF, Ko YH, Torbenson MS, et al. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res, 2002, 62 : 3909-3913.

共引文献15

同被引文献33

  • 1董立,战光绪,吴大正.金复康对二甲肼诱导的大鼠结直肠癌癌前病变的抑制作用[J].中成药,2007,29(7):1061-1063. 被引量:6
  • 2Agrawal N, Dasaradhi PV, Mohmmed A, et al. RNA interference., biology, mechanism, and applications[J ]. Microbiol Mol Biol Rev, 2003,67:657-685.
  • 3Barik S. Silence of the transcripts: RNA interference in medicine[J].J Mol Med, 2005, 83(10): 764-773.
  • 4Lasithiotakis KG, Sinnberg TW, Schittek B, et al. Combined inhibition of MAPK and roTOR signaling inhibits growth, induces cell death, and abrogates in vasive growth of melanoma cells[J]. J Invest Dermatol,2008 ,128(8) :2013-2023.
  • 5Sahin F, Kannangai R, Adegbola O,et al. roTOR and P70 S6 kinase expression in primary liver neoplasms [J]. Clin Cancer Res,2004,10(24):8421 -2845.
  • 6Rizell M, Lindner P. Inhibition of mTOR suppresses experimental liver tumours[J]. Antieancer Res,2005 , 25 (2A) : 789-793.
  • 7Menon S, Manning BD. Common corruption of the mTOR signaling network in human tumors[J]. Oncogene. 2008 ,27(Suppl 2):S43- 51.
  • 8Borkhardt A. Blocking oncogenes in malignant cells by RNA interference-new hope for a highly specific cancer treatment[J]. Cancer Cell,2002,2(3) : 167 168.
  • 9Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer:worldwide incidence and trends[J].Gastroenterology, 2004,127(5):5 -16.
  • 10Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia[J].Surgeon, 2005, 3(3): 210- 215.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部